Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
CC transcript
Inv. presentation
Credit agrmnt [a]
Acq. announced
Director departure
Appointed director
Employment agrmnt
|
|
AMAG PHARMACEUTICALS, INC. (AMAG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| Palo Alto Investors LP reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G/A
| Camber Capital Management LP reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/07/2020 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G/A
| Palo Alto Investors, LLC reports a 9% stake in AMAG Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/27/2019 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 11.8% stake in AMAG Pharmaceuticals, Inc. |
| 05/20/2019 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 9.9% stake in AMAG Pharmaceuticals, Inc. |
| 04/08/2019 |
SC 13G/A
| Jackson Square Partners, LLC reports a 0.3% stake in AMAG Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Palo Alto Investors, LLC reports a 9.8% stake in AMAG Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/24/2019 |
SC 13G/A
| BlackRock Inc. reports a 15.8% stake in AMAG PHARMACEUTICALS INC |
| 02/14/2018 |
SC 13G/A
| Palo Alto Investors, LLC reports a 9.9% stake in AMAG Pharmaceuticals, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| FMR LLC reports a 4.6% stake in AMAG PHARMACEUTICALS INC |
| 02/08/2018 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.5% stake in AMAG Pharmaceuticals Inc |
| 02/06/2018 |
SC 13G/A
| JANUS CAPITAL MANAGEMENT LLC reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 01/23/2018 |
SC 13G/A
| BlackRock Inc. reports a 15.5% stake in AMAG PHARMACEUTICALS INC |
| 07/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/25/2017 |
SC 13G/A
| Camber Capital Management LLC reports a 4.8% stake in AMAG Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.4% stake in AMAG PHARMACEUTICALS, INC. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/10/2017 |
SC 13G/A
| AMAG PHARMACEUTICALS INC. reports a 4.2% stake in EXIT FILING AMAG PHARMACEUTICALS, INC. |
| 02/09/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/08/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/12/2017 |
SC 13G/A
| Palo Alto Investors, LLC reports a 9.8% stake in AMAG Pharmaceuticals, Inc. |
| 01/12/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
|
|
|